Safety Study of MGAH22 in HER2-positive Carcinomas

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Green Cross Corporation
Information provided by (Responsible Party):
MacroGenics
ClinicalTrials.gov Identifier:
NCT01148849
First received: June 17, 2010
Last updated: August 24, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)